Clinton: SCOTUS Myriad Genetics Decision 'Terrific'

June 14 (Bloomberg) -- Former President Bill Clinton discusses the U.S. Supreme Court's decision in Association for Molecular Pathology v. Myriad Genetics, Inc. with Trish Reagan at the Clinton Global Initiative in Chicago. The ruling, which found human genes cannot be patented, will "generate untold thousands of jobs in this country," he says.

The World Is Not Levered to the New China: UBS
58:26 - Bhanu Baweja, global head of emerging market cross asset strategy at UBS, discusses the 25th anniversary of the Shanghai Stock Exchange and the outlook for China's economy and emerging markets. He speaks to Bloomberg's Anna Edwards and Guy Johnson on "Countdown." (Source: Bloomberg)
  • Investing in Russia: Is Now the Time to Get In?
  • Russia Will Deliver Positive Returns in 2016: UBS
  • Russian Relations: Is There a Thaw With the West?